In collaboration with the Maine Medical Center Cancer Institute and Spectrum Medical Group, Chest Medicine Associates is pleased to announce our participation in the Maine Comprehensive Lung Cancer Screening Program. Individuals who may be eligible for lung cancer screening include those who:
If you meet all three criteria, you may benefit from participation in the comprehensive lung cancer screening program, which includes the following services:
Please visit http://www.mmc.org/lungcancerscreening for more detailed information. If you are eligible and would like more information about this program, please Chest Medicine Associates at (207) 828-1122, extension 108
Methacholine challenge testing is one method of assessing airway responsiveness. Airway hyperresponsiveness is one of the features that may contribute to a diagnosis of asthma.
Methacholine challenge testing (MCT) is most often considered when asthma is a serious possibility and traditional methods, most notably spirometry performed before and after administration of a bronchodilator, have not established or eliminated the diagnosis.
Methacholine challenge testing is also a valuable tool in the evaluation of occupational asthma. Methcholine challenge testing is sometimes used to determine the relative risk of developing asthma, assess the severity of asthma, and assess response to asthma therapy although its clinical use in these areas has not been well established.
Home Sleep testing uses a portable device that may aid in the diagnosis of sleep disordered breathing in adults. The test monitors nasal airflow, blood oxygen level, pulse and respiratory effort.